CTLA4 and non-small cell lung carcinoma: A prospective observational clinical study dissected associations between HLA-DRB1*11:01 and pruritus, and between HLA-DQB1*03:01 and colitis in metastatic NSCLC and melanoma patients receiving anti-PD-1, anti-CTLA4, or both (165) (Figure 2).